| |
| |
|
| Insider
Information: |
Ciechanover Isaac E. |
| Relationship: |
Chief Executive Office... |
| City: |
Brisbane |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
332,243 |
|
|
Indirect Shares
|
290,687 |
|
|
| Direct
Value |
$230,344 |
|
|
|
Indirect Value
|
$201,533 |
|
|
| Total
Shares |
622,930 |
|
|
| Total
Value |
$431,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Atara Biotherapeutics, Inc. |
ATRA |
Chief Executive Office... |
2019-05-30 |
332,243 |
2019-05-30 |
290,687 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
209 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-26 |
4 |
AS |
$17.35 |
$62,460 |
I/I |
(3,600) |
356,311 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-16 |
4 |
AS |
$30.38 |
$18,228 |
I/I |
(600) |
359,478 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-05-25 |
4 |
AS |
$18.03 |
$64,908 |
I/I |
(3,600) |
359,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-12 |
4 |
AS |
$30.05 |
$3,005 |
I/I |
(100) |
360,078 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-11 |
4 |
AS |
$21.49 |
$438,900 |
I/I |
(20,000) |
360,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-26 |
4 |
AS |
$20.15 |
$2,015 |
I/I |
(100) |
363,511 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-25 |
4 |
AS |
$20.12 |
$24,144 |
I/I |
(1,200) |
363,611 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-12 |
4 |
AS |
$20.20 |
$24,240 |
I/I |
(1,200) |
364,811 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-11 |
4 |
AS |
$20.42 |
$245,244 |
I/I |
(12,010) |
366,011 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-23 |
4 |
AS |
$15.25 |
$36,600 |
I/I |
(2,400) |
372,978 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-28 |
4 |
AS |
$39.20 |
$102,877 |
I/I |
(2,600) |
374,982 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-22 |
4 |
AS |
$15.17 |
$36,473 |
I/I |
(2,400) |
375,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2019-02-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,683) |
375,611 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-08-27 |
4 |
AS |
$38.15 |
$101,209 |
I/I |
(2,600) |
377,582 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-07 |
4 |
AS |
$17.30 |
$62,280 |
I/I |
(3,600) |
377,778 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-04-01 |
4 |
AS |
$20.04 |
$17,836 |
I/I |
(890) |
378,021 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-03-31 |
4 |
AS |
$20.01 |
$6,003 |
I/I |
(300) |
378,911 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-01-14 |
4 |
AS |
$20.07 |
$24,084 |
I/I |
(1,200) |
379,211 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2018-01-10 |
4 |
AS |
$19.64 |
$171,938 |
I/I |
(8,600) |
380,178 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-31 |
4 |
AS |
$55.41 |
$146,214 |
I/I |
(2,600) |
380,182 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-01-13 |
4 |
AS |
$20.32 |
$24,384 |
I/I |
(1,200) |
380,411 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2016-12-06 |
4 |
AS |
$18.55 |
$66,780 |
I/I |
(3,600) |
381,378 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-12-31 |
4 |
AS |
$26.00 |
$32,136 |
I/I |
(1,200) |
381,611 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-07-30 |
4 |
AS |
$56.05 |
$145,946 |
I/I |
(2,600) |
382,782 |
0 |
- |
|
| ATRA |
Atara Biotherapeutics, In... |
Chief Executive Officer |
• • – |
2015-12-30 |
4 |
AS |
$25.21 |
$30,252 |
I/I |
(1,200) |
382,811 |
0 |
- |
|
209 Records found
|
|
Page 5 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
